Cervical Fusion

Fusion rates of 97.6% at 12 months and 100% at 18 months when OSTEOAMP was used, exceed fusion rates reported in the literature for traditional DBMs.3
OSTEOAMP is a differentiated allograft, uniquely processed with the bone and the bone marrow to retain multiple growth factors.1*
OSTEOAMP formats include granules and putty.
Explore our OSTEOAMP SELECT formats (flowable, fibers, sponges).
See clinical dataOSTEOAMP granules combine osteoconductive and osteoinductive properties with mineralized cortical-cancellous allograft chips.
*In vitro performance may not be predictive of performance in humans.
All formats may be rehydrated with bone marrow aspirate, blood, or saline.
Fusion rates of 97.6% at 12 months and 100% at 18 months when OSTEOAMP was used, exceed fusion rates reported in the literature for traditional DBMs.3
A higher percentage of patients achieved fusion in the OSTEOAMP group at all time points than the in the rhBPM-2 group (p<0.01). Total time for fusion for OSTEOAMP was approximately 40% shorter than that of rhBPM-2 (207.9 and 333.9 days, respectively).2
To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.
Instructions For Use
OSTEOAMP – DCI Doner Services Tissue Bank
OSTEOAMP – Lifelink Tissue Bank
OSTEOAMP – CTS
Material Management Packet
OSTEOAMP – Material Management Packet